FK866 (APO866, Daporinad),NAMPT抑制剂

FK866 (APO866, Daporinad) (订货以英文为准)

编号:F127321
CAS号:658084-64-1
分子式:C24H29N3O2
分子量:391.51
货号 品牌 包装 目录价 您的价格 库存 数量 购买
F127321-100mg 阿拉丁 100mg ¥5767.90
F127321-25mg 阿拉丁 25mg ¥2059.90
F127321-5mg 阿拉丁 5mg ¥529.90
产品名称 FK866 (APO866, Daporinad)
中文名称 FK866 (APO866, Daporinad),NAMPT抑制剂
CAS号 658084-64-1
分子式(M.F.) C24H29N3O2
分子量(M.W.) 391.51
储存条件 -20°C储存
敏感性易吸湿
溶解性Soluble in ethanol (78 mg/ml at 25 °C), DMF (40 mg/ml), DMSO (100 mg/ml), PBS (pH 7.2) (~0.5 mg/ml), and water (<1 mg/ml at 25 °C), DMSO 25mg/ml Ethanol dimethyl formamide
存贮条件储存温度-20°C
应用A highly specific non-competitive inhibitor of NAMPT
产品介绍FK866 (APO866, Daporinad)有效抑制烟酰胺磷酸核糖转移酶(NMPRTase),无细胞试验中IC50为0.09 nM。Phase 1/2。
备注APO866 effectively inhibits nicotinamide phosphoribosyltransferase (NMPRTase) with IC50 of 0.09 nM. Phase 1/2.
生化机理FK-866 has been shown to induce apoptosis by non-competitive, and specific inhibition of nicotamide phosphoribosyltransferase (NAMPT). NAMPT is a key regulatory enzyme that mediates NAD+ biosynthesis within cells. Mechanistic studies show that this compound contains an enzymatic active site of visfatin which is optimized for nicotinamide binding and inhibition. Visfatin also contains a similar structure to insulin and mimics its actions by binding to the insulin receptors.
别名(2E)-N-[4-(1-苯甲酰基-4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺;Daporinad; APO866; FK-866; FK 866; APO 866; APO-866;(E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-(pyridin-3-yl)acrylamide
标识符号https://www.aladdin-e.com/images/ghs/ghs06.jpg
信号词Danger
危害声明H301
警示性声明P301 + P310
WGK德国3
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:148940-94-7
¥ 3520.00 H849672-250mg
CAS号:5970-62-7
¥ 159.00 Z836619-5g
CAS号:1701-93-5
¥ 136.00 S817960-1g
CAS号:6966-10-5
¥ 162.00 D837845-10g
CAS号:7783-96-2
¥ 783.00 S818364-25g
CAS号:36873-96-8
¥ 960.00 T823175-100mg
CAS号:916420-21-8
¥ 39.00 F828981-250mg
CAS号:1186667-20-8
¥ 480.00 P837187-100mg
CAS号:931-33-9
¥ 194.00 B823213-5g